These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

722 related articles for article (PubMed ID: 19263272)

  • 1. Clinical use of proton-pump inhibitors but not H2-blockers or antacid/alginates raises the serum levels of amidated gastrin-17, pepsinogen I and pepsinogen II in a random adult population.
    Agréus L; Storskrubb T; Aro P; Ronkainen J; Talley NJ; Sipponen P
    Scand J Gastroenterol; 2009; 44(5):564-70. PubMed ID: 19263272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Helicobacter pylori eradication improves gastric histology and decreases serum gastrin, pepsinogen I and pepsinogen II levels in patients with duodenal ulcer.
    Pimanov SI; Makarenko EV; Voropaeva AV; Matveenko ME; Voropaev EV
    J Gastroenterol Hepatol; 2008 Nov; 23(11):1666-71. PubMed ID: 17559360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship among serum pepsinogens, serum gastrin, gastric mucosal histology and H. pylori virulence factors in a paediatric population.
    Lopes AI; Palha A; Lopes T; Monteiro L; Oleastro M; Fernandes A
    Scand J Gastroenterol; 2006 May; 41(5):524-31. PubMed ID: 16638693
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum pepsinogen I, pepsinogen II, and gastrin 17 in relatives of gastric cancer patients: comparative study with type and severity of gastritis.
    Haj-Sheykholeslami A; Rakhshani N; Amirzargar A; Rafiee R; Shahidi SM; Nikbin B; Khosravi F; Massarrat S
    Clin Gastroenterol Hepatol; 2008 Feb; 6(2):174-9. PubMed ID: 18237867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Detection of gastric preneoplastic lesions with serum levels of pepsinogen in Chilean subjects].
    Fernández F JI; de Aretxabala U X; Santander D R; Sabah T S; Maira S J; Navarro R A; Planzer D M; Gómez L F; Etchart M; Gallegos I; Torrens X; Fasce P G; Reydet I
    Rev Med Chil; 2007 Dec; 135(12):1519-25. PubMed ID: 18357351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Examination of serum pepsinogen in functional dyspepsia.
    Tahara T; Shibata T; Okubo M; Yamashita H; Yoshioka D; Yonemura J; Maruyama N; Kamano T; Kamiya Y; Fujita H; Nakagawa Y; Nagasaka M; Iwata M; Yamada H; Nakamura M; Arisawa T; Hirata I
    Hepatogastroenterology; 2012; 59(120):2516-22. PubMed ID: 23178618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacterpylori antibodies in the management of dyspeptic patients in primary care.
    Germaná B; Di Mario F; Cavallaro LG; Moussa AM; Lecis P; Liatoupolou S; Comparato G; Carloni C; Bertiato G; Battiestel M; Papa N; Aragona G; Cavestro GM; Iori V; Merli R; Bertolini S; Caruana P; Franzé A
    Dig Liver Dis; 2005 Jul; 37(7):501-8. PubMed ID: 15975537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
    Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
    J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Noninvasive evaluation of Helicobacter pylori therapy: role of fasting or postprandial gastrin, pepsinogen I, pepsinogen II, or serum IgG antibodies.
    Al-Assi MT; Miki K; Walsh JH; Graham DP; Asaka M; Graham DY
    Am J Gastroenterol; 1999 Sep; 94(9):2367-72. PubMed ID: 10483993
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of antisecretory treatment with proton pump inhibitors on serum pepsinogen I levels.
    Di Mario F; Ingegnoli A; Altavilla N; Cavallaro LG; Bertolini S; Merli R; Cavestro GM; Iori V; Maino M; Leandro G; Franzè A
    Fundam Clin Pharmacol; 2005 Aug; 19(4):497-501. PubMed ID: 16011738
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes with aging in gastric biomarkers levels and in biochemical factors associated with
    Shan JH; Bai XJ; Han LL; Yuan Y; Sun XF
    World J Gastroenterol; 2017 Aug; 23(32):5945-5953. PubMed ID: 28932086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between gastric secretion and type of early gastric carcinoma.
    Yoshihara M; Haruma K; Sumii K; Watanabe C; Kiyohira K; Kawaguchi H; Tanaka S; Kajiyama G
    Hiroshima J Med Sci; 1995 Sep; 44(3):79-82. PubMed ID: 8567316
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum gastrin and pepsinogens do not correlate with the different grades of severity of gastro-oesophageal reflux disease: a matched case-control study.
    Monkemuller K; Neumann H; Nocon M; Vieth M; Labenz J; Willich SN; Stolte M; Hocker M; Jaspersen D; Lind T; Malfertheiner P
    Aliment Pharmacol Ther; 2008 Aug; 28(4):491-6. PubMed ID: 18557987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of omeprazole and lansoprazole on fasting and postprandial serum gastrin and serum pepsinogen A and C.
    Iwao T; Toyonaga A; Kuboyama S; Tanikawa K
    Hepatogastroenterology; 1995; 42(5):677-82. PubMed ID: 8751234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pepsinogen gastrin mesor ratio: a potential simple marker for gastric secretory function.
    Tarquini B; Benvenuti M; Cavallini V; Cecchettin M; Romano S; Sensi G
    Chronobiologia; 1984; 11(1):11-7. PubMed ID: 6723472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum pepsinogen I and gastrin in peptic ulcer patients using nonsteroidal anti-inflammatory drugs.
    Kemppainen H; Räihä I; Sourander L
    Hepatogastroenterology; 1997; 44(16):1143-6. PubMed ID: 9261614
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between abnormal gastric function risk and Helicobacter pylori infection assessed by ELISA and 14C-urea breath test.
    Gong Y; Wei W; Yuan Y
    Diagn Microbiol Infect Dis; 2014 Dec; 80(4):316-20. PubMed ID: 25284372
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Follow-up study on a high risk population of gastric cancer in north China by serum pepsinogen assay.
    Sun LP; Gong YH; Wang L; Gong W; Yuan Y
    J Dig Dis; 2008 Feb; 9(1):20-6. PubMed ID: 18251790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.